# NEVIRAPINE TABLETS FOR ORAL SUSPENSION
> **NDA022299** · New Drug Application · Sponsor: AUROBINDO PHARMA LTD · Approved 2010-02-24
## Drug
- **FDA Application Number:** NDA022299
- **Application type:** New Drug Application
- **Brand name:** NEVIRAPINE TABLETS FOR ORAL SUSPENSION
- **Generic name:** Nevirapine
- **Active ingredients:** NEVIRAPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AUROBINDO PHARMA LTD
- **First approval:** 2010-02-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022299)
---
*MORVS · CC0 1.0*